- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Trial Phase
Trial Status
Paid Participation
Trial Details
Key Eligibility Criteria
992 Participants Needed
Trial Details
Key Eligibility Criteria
381 Participants Needed
Trial Details
Key Eligibility Criteria
550 Participants Needed
Trial Details
Key Eligibility Criteria
330 Participants Needed
Trial Details
Key Eligibility Criteria
118 Participants Needed
Trial Details
Key Eligibility Criteria
99 Participants Needed
Trial Details
Key Eligibility Criteria
2650 Participants Needed
Trial Details
Key Eligibility Criteria
220 Participants Needed
Trial Details
Key Eligibility Criteria
358 Participants Needed
Trial Details
Key Eligibility Criteria
150 Participants Needed
Trial Details
Key Eligibility Criteria
50 Participants Needed
Trial Details
Key Eligibility Criteria
87 Participants Needed
Trial Details
Key Eligibility Criteria
80 Participants Needed
Trial Details
Key Eligibility Criteria
237 Participants Needed
Trial Details
Key Eligibility Criteria
120 Participants Needed
Trial Details
Key Eligibility Criteria
650 Participants Needed
Trial Details
Key Eligibility Criteria
15 Participants Needed
Trial Details
Key Eligibility Criteria
15 Participants Needed
Trial Details
Key Eligibility Criteria
32 Participants Needed
Trial Details
Key Eligibility Criteria
18 Participants Needed
"I wasn’t diagnosed until February, but I showed symptoms over ten years before. I want to help find a cure. I have lost family members to Parkinson’s and want to contribute to the search for better treatments before my children possibly come down with it."
"I have 5 kids. I'll do anything I can to slow this disease down in hopes that I can stay active with them into their adulthood. I also feel I am serving the greater good for all those who suffer from Parkinson's. Since I'm self employed, my schedule is flexible. "
"My dad was in a research group for Parkinson's for about 6 years, which was very interesting. I was just diagnosed 1.5 years ago, and started on low dose Sinemet. Doing well on Sinemet, but I'd like to get ahead of the condition. I'm excited about participating in research. "
"It seems my Parkinson’s is progressing more rapidly now. And my meds are lagging behind. My off time is more frequent and the episodes are longer. Trying to figure out what my options are."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
Trial Details
Key Eligibility Criteria
12 Participants Needed
Trial Details
Key Eligibility Criteria
30 Participants Needed
Trial Details
Key Eligibility Criteria
62 Participants Needed
Trial Details
Key Eligibility Criteria
60 Participants Needed
Trial Details
Key Eligibility Criteria
132 Participants Needed
Trial Details
Key Eligibility Criteria
314 Participants Needed
Trial Details
Key Eligibility Criteria
316 Participants Needed
Trial Details
Key Eligibility Criteria
214 Participants Needed
Trial Details
Key Eligibility Criteria
50 Participants Needed
Trial Details
Key Eligibility Criteria
7 Participants Needed
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Parkinson's Disease trials in California 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in California for Parkinson's Disease is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in California several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added Fecal Microbiota Transplant for Parkinson's Disease, Illumina 3D Deep Brain Stimulation for Parkinson's Disease and Blood Flow Restriction and Exercise for Parkinson's Disease to the Power online platform.